85 results on '"Undar B"'
Search Results
2. IS BERLIN-FRANKFURT-MUNSTER (BFM) REGIMEN FEASIBLE FOR TREATMENT OF ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: RETROSPECTIVE ANALYSIS OF OUTCOME OF ADULT ALL TREATED WITH BFM AND HPER-CVAD PROTOCOLS
3. IPSET-THROMBOSIS BETTER IDENTIFIES THROMBOSIS FREE SURVIVAL
4. HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHEN ADJUSTED WITH COMORBIDITIES
5. Maximum storage time that affect the viability of stem cells
6. Situations affecting hematopoietic stem cell apheresis
7. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia
8. RENAL AND NEUROLOGICAL RESPONSE WITH ECULIZUMAB IN A PATIENT WITH TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
9. EFFICACY OF POSACONAZOLE PROPYLAXIS IN AML INDUCTION THERAPY, SINGLE CENTER EXPERIENCE
10. Prognostic value of comorbidity indexes in MDS
11. JAK2V617F mutation and thrombosis in the myeloproliferative neoplasms
12. 247 HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHEN ADJUSTED WITH COMORBIDITIES
13. Multiple myeloma presenting as massive ascites
14. Primary thyroid lymphoma: case series with literature review
15. A patient with diffuse large B-cell non-Hodgkin's lymphoma and AA type amyloidosis
16. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 37 patients
17. Neutrophil apoptosis in patients with beta thalassemia major
18. Analysis of thalassemia syndromes and abnormal hemoglobins in patients from the Aegean region of Turkey
19. Increased levels of tissue factor pathway inhibitor may reflect disease activity and play a role in thrombotic tendency in Behçet's disease
20. Emergence of Philadelphia positive chronic myeloid leukemia in a patient with Philadelphia negative acute lymphoblastic leukemia
21. P-263 Prognostic value of comorbidity indexes in MDS
22. Flow cytometric analysis of circadian changes in platelet activation using anti-GMP-140 (P-selectin) monoclonal antibody
23. 85 Chacteristics and clinical features of 193 patients with myelodys-plastic syndromes: Experience of two centers from Turkey
24. THE EFFECT OF EXERCISE ON FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEALTHY VOLUNTEERS
25. P114 Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 37 patients
26. PO002 The clinical, hematological and morphological profile of patients with myelodysplastic syndromes: a single institution experienc
27. Infarction of an accessory spleen secondary to splenic vein thrombosis in essential thrombocytosis
28. Bilateral breast involvement in Sézary syndrome.
29. High Lactoferrin Levels in Disseminated Intravascular Coagulation and Its Possible Negative Role in Coagulation
30. ONCOGENOUS OSTEOMALACIA - REPORT OF A CASE
31. Plasma thrombin activatable fibrinolysis inhibitor levels in Behcet's disease
32. P-263 Prognostic value of comorbidity indexes in MDS.
33. Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up.
34. A Comparison of Fresenius Com.Tec Cell and Spectra Optia Cell Separators for Autologous and Allogeneic Stem Cell Collections: Single Center Experience.
35. Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
36. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
37. Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
38. Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
39. Ex vivo evaluation of the effect of regulatory T cells on the anti-tumor activity of bortezomib in multiple myeloma.
40. IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish Cohort.
41. Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities.
42. Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers.
43. Ischemic stroke after recombinant factor VIIa treatment in acquired hemophilia A patient.
44. Fatal disseminated mucormycosis in a patient with mantle cell non-Hodgkin's lymphoma: an autopsy case.
45. Primary thyroid lymphoma: case series with literature review.
46. Prognostic significance of immunohistochemical classification of diffuse large B-cell lymphoma.
47. Multiple myeloma presenting as massive ascites.
48. A patient with diffuse large B-cell non-Hodgkin's lymphoma and AA type amyloidosis.
49. The clinical, haematological and morphological profile of patients with myelodysplastic syndromes: a single institution experience from Turkey.
50. Increased concentration of soluble CD40 ligand in preeclampsia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.